Extracting clarity from biological complexity
An End-to-End Platform for Reliable Biomarker Discovery
Our Process
01
Capture
Collection of patient samples and acquisition of high-dimensional biological data using state-of-the-art technologies such as CyTOF, Olink, and multiplex transcriptomics.
02
Decode
Integration and structuring of complex multiomic data through advanced AI/ML pipelines to reveal relevant biological signals and reduce dimensionality.
03
Identify
Extraction of robust, stable, and interpretable biomarker signatures using Stabl, our proprietary algorithm specifically designed for clinical-grade discovery.
04
Translate
Development of clinically compatible assays based on the identified signatures, enabling applications in diagnostics, risk prediction, and personalized patient management.
From Data to Decisions
A state-of-the-art platform turning immune signals into actionable clinical insights
At the core of SurgeCare’s platform lies Stabl — a proprietary technology designed to extract robust and interpretable biological fingerprints from high-dimensional multiomics data.
Built on over a decade of interdisciplinary research in systems biology, statistics, and machine learning, Stabl identifies a shortlist of stable and predictive biomarkers — not just for discovery, but amenable to real-world clinical application.
This unique capability allows us to transform noisy and heterogeneous datasets into clinically actionable biological fingerprints — enabling early detection, risk stratification, and personalized decision-making across a wide range of conditions.
Our platform opens the door to a new generation of biomarkers that are reliable, reproducible, and ready for clinical use.
We’re Here to Help
Ready to translate your complex multiomic data into real-world clinical applications? Contact us today to learn more about our innovative solutions and expert services.
